Faster global financial news!
Shijiazhuang Pharmaceutical Group: Nintedanib Mesylate Inhalation Powder Receives Approval for Clinical Trials in China
Shandong Pharmaceutical Group (01093.HK) announced in Hong Kong that the nintedanib mesylate inhalation powder developed by the Group has been approved by China’s National Medical Products Administration (NMPA) to conduct clinical trials in China. This product is the first inhalation formulation approved in China for the clinical treatment of pulmonary fibrosis. Nintedanib mesylate is a multi-targeted tyrosine kinase inhibitor capable of slowing the progression of idiopathic pulmonary fibrosis (IPF). The currently marketed formulation is an oral soft capsule.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
GRAM (Gram, prev. Toncoin) price pulls back to $1.057, hitting a nearly 365-day low
-
2
BCH (Bitcoin Cash) trading volume reached $2.1 million over the past hour (15.2x its average for the same period over the past 7 days), currently trading at $247.900.
-
3
2026 US Stock Market Safe-Haven Assets Encyclopedia: How Walmart and Caterpillar Lead the Industrial Sector Amid AI Bubble Doubts
-
4
Current Status of BUSD (Binance USD): Issuance Halted, Orderly Wind-Down Underway
-
5
What Cryptocurrency Is ADR? A Deep Dive into the Solana Meme Project American Dollar Reserve
-
6
How is BFHT doing? What is the future outlook for BFHT?
-
7
What is the METIS Token? An Analysis of Metis' Technical Architecture and Transition Progress
-
8
Challenges and Issues Facing Ethereum Even After the Completion of the Ethereum 2.0 Upgrade
-
9
USDT Perpetual Contract Auto-Margin Deposition: Mechanism, Trigger Conditions, and Risks
-
10
US military says it struck a cargo ship in the Gulf of Oman suspected of violating US blockade on Iran
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
